Pages that link to "Q34218500"
Jump to navigation
Jump to search
The following pages link to Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals (Q34218500):
Displaying 29 items.
- Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells (Q28554212) (← links)
- A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines? (Q29994671) (← links)
- Adenoviral vectors as novel vaccines for influenza. (Q30370445) (← links)
- Expression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells. (Q33635315) (← links)
- HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV. (Q33869332) (← links)
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial (Q34469018) (← links)
- Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge (Q34992660) (← links)
- Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection. (Q36046570) (← links)
- New prospects for a preventive HIV-1 vaccine (Q36223864) (← links)
- Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques (Q37499531) (← links)
- Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir (Q38777005) (← links)
- Loss of immune control in HIV-infected patients: how does mucosal candidiasis occur? (Q38786612) (← links)
- HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response. (Q40057846) (← links)
- Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial (Q40075275) (← links)
- Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial (Q40332276) (← links)
- Synthetic biology approach for the development of conditionally replicating HIV-1 vaccine (Q41923238) (← links)
- Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120. (Q46633111) (← links)
- Novel Concepts for HIV Vaccine Vector Design (Q47112156) (← links)
- Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease. (Q52719601) (← links)
- Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. (Q52730779) (← links)
- CD4 T Cell Subsets and Pathways to HIV Latency (Q59359728) (← links)
- Regulating Innate and Adaptive Immunity for Controlling SIV Infection by 25-Hydroxycholesterol (Q59813471) (← links)
- Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers (Q60908099) (← links)
- Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation (Q64229887) (← links)
- Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV (Q90226623) (← links)
- Epigenetic suppression of HIV in myeloid cells by the BRD4-selective small molecule modulator ZL0580 (Q90437486) (← links)
- Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models (Q92340123) (← links)
- T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers (Q94562592) (← links)
- Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine (Q97586951) (← links)